-
Views
-
Cite
Cite
Stephen J Nicholls, Pia Lundman, Jean-Claude Tardif, Diabetic dyslipidemia: extending the target beyond LDL cholesterol, European journal of cardiovascular prevention and rehabilitation, Volume 17, Issue 1_suppl, 1 May 2010, Pages s20–s24, https://doi.org/10.1097/01.hjr.0000368195.09485.17
- Share Icon Share
Abstract
Lowering low-density lipoprotein cholesterol plays an important role in therapeutic strategies designed to reduce cardiovascular risk. However, the residual clinical risk in statin trials suggests that additional therapies will be required to achieve more effective prevention of cardiovascular disease. The high prevalence of hypertriglyceridemia and low levels of high-density lipoprotein cholesterol in diabetes presents further targets for the development of new cardioprotective therapies. Eur J Cardiovasc Prev Rehabil 17 (Suppl 1):S20-S24 © 2010 The European Society of Cardiology
Comments